Ferring and IMAB sign licensing agreement granting IMAB exclusive rights in Asia to olamkicept for the treatment of autoimmune disease
-Ferring Pharmaceuticals and IMAB today announced that they have signed a licensing agreement which grants IMAB exclusive rights…
Ferring receives EU approval for REKOVELLE® (follitropin delta)
-Ferring Pharmaceuticals announced today that the European Commission (EC) has granted marketing authorisation for REKOVELLE®…
Ferring Pharmaceuticals collaborates with MetaboGen AB on development of microbiome-based treatment for intrahepatic cholestasis of pregnancy (ICP)
-Ferring Pharmaceuticals and MetaboGen AB today announced a multi-year research collaboration…
Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos collaborate on nanotechnology R&D platform
-Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos today announced a long-term collaboration aimed at improving…
Ferring receives positive CHMP opinion for REKOVELLE® (follitropin delta)
-Ferring Pharmaceuticals announced today that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion…
Archives Press release 2016
Archives Press release 2016